A randomized, double-blind trial evaluating the safety and immunogenicity of an influenza vaccine with reduced preservative (FluLaval TR) [SPD 707] and a standard influenza vaccine (Fluarix) in subjects between 18-60 and over 60 years of age
Phase of Trial: Phase III
Latest Information Update: 11 Oct 2016
At a glance
- Drugs GSK 1536489A; Influenza virus vaccine
- Indications Influenza virus infections
- Focus Pharmacodynamics
- Sponsors GlaxoSmithKline
- 26 Feb 2009 Additional locations identified as reported by ClinicalTrials.gov, last updated 26 Feb 2009.
- 09 May 2007 New trial record.